Tandoi, F <br/><br/>
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.  [electronic resource] 

 -  Transplantation proceedings  Sep 2014 
 - 2308-11 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2014.07.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis B--diagnosis<br/>Hepatitis B Surface Antigens--blood<br/>Humans<br/>Immunoglobulins--therapeutic use<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Liver Transplantation<br/>Male<br/>Middle Aged<br/>Postoperative Care--methods<br/>Postoperative Complications--diagnosis<br/>Recurrence<br/>Treatment Outcome